Chicago Capital Management’s Immune Design Corp. IMDZ Stock Holding History
Bought
Maintained
Sold
Chicago Capital Management's IMDZ Position: Q2 2019 in Review
Chicago Capital Management sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 11,816 shares — an estimated $69K sold.
Chicago Capital Management first reported a position in IMDZ in Q1 2019 and held it in 1 quarter. The position peaked at $69K in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.
- Chicago Capital Management reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
- Chicago Capital Management sold 11,816 Immune Design Corp. shares in Q2 2019, an estimated $69K.
- Chicago Capital Management first reported a position in Immune Design Corp. in Q1 2019 and held it in 1 quarter.
- Chicago Capital Management's Immune Design Corp. position peaked at $69K in Q1 2019.
- 0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.
Based on Chicago Capital Management's 13F filing for Q2 2019, filed 12 Aug 2019.